Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M4XO
|
|||
Drug Name |
PMID25514969-Compound-Figure2-4
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Takeda Pharmaceutical Co. Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H15F3N4O3
|
|||
Canonical SMILES |
C1CC2COCC1N2C(=O)C3=CN=C4N3C=C(C=C4C5=CN=CO5)C(F)(F)F
|
|||
InChI |
1S/C18H15F3N4O3/c19-18(20,21)10-3-13(15-5-22-9-28-15)16-23-4-14(24(16)6-10)17(26)25-11-1-2-12(25)8-27-7-11/h3-6,9,11-12H,1-2,7-8H2
|
|||
InChIKey |
OANZLTUUAVMTHM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cholesterol 24-hydroxylase (CYP46A1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Cholesterol 24-hydroxylase (CYP46A1) | Target's Patent Info | [1] | |
KEGG Pathway | Primary bile acid biosynthesis | |||
Pathwhiz Pathway | Bile Acid Biosynthesis | |||
Reactome | Endogenous sterols | |||
WikiPathways | Metapathway biotransformation | |||
Oxidation by Cytochrome P450 | ||||
Phase 1 - Functionalization of compounds | ||||
Bile acid and bile salt metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).Expert Opin Ther Pat. 2015 Mar;25(3):373-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.